ConvaTec Aktie
| 2,86EUR | 0,06EUR | 2,14% |
WKN DE: A2AUD3 / ISIN: GB00BD3VFW73
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 10 142 | 10 036 | 10 136 | 10 489 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,15 | 0,17 | 0,17 | 0,17 | 0,00 |
Bilanz (in Mio. GBP) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 820 | 739 | 682 | 633 | 699 |
| Summe Anlagevermögen | 1 892 | 2 247 | 2 231 | 2 173 | 2 112 |
| Summe Aktiva | 2 713 | 2 986 | 2 913 | 2 807 | 2 811 |
Bilanz (in Mio. GBP) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 1 461 | 1 648 | 1 585 | 1 458 | 1 682 |
| Summe Eigenkapital | 1 251 | 1 338 | 1 328 | 1 349 | 1 129 |
| Summe Passiva | 2 713 | 2 986 | 2 913 | 2 807 | 2 811 |
Adresse
| Convatec, Eastborne Terrace, W2 6LG Paddington | |
| Telefon | +44 (11) 89528100 |
| Internet | http://www.convatec.com |
Management
|
Anne Belcher
President & COO-Global Emerging Markets |
|
Brian Michael May
Independent Non-Executive Director |
|
Constantin Coussios
Independent Non-Executive Director |
|
David Phillips
Treasury & Head-Investor Relations |
|
Divakar Ramakrishnan
CTO, Head-Research & Development & EVP |
|
Emma Rose
Chief People Officer & Executive Vice President |
|
Evelyn Douglas
EVP, Chief Strategy & Business Development officer |
|
Fiona Victoria Ryder
Chief Financial Officer & Financial Controller |
|
Heather L. Mason
Independent Non-Executive Director |
|
James Edward Spencer Kerton
Secretary, General Counsel & Executive VP |
|
John David Gibson McAdam
Chairman |
|
John Haller
Executive VP, Chief Quality & Operations Officer |
|
Jonathan Peter Mason
Chief Executive Officer & Director |
|
Kimberly S. Lody
Independent Non-Executive Director |
|
Kjersti Grimsrud
President & Chief Operating Officer-Infusion Care |
|
Margaret Ewing
Senior Independent Non-Executive Director |
|
Sharon L. O'Keefe
Independent Non-Executive Director |